Illumina Soars After Crushing Expectations for Q2

Illumina Soars After Crushing Expectations for Q2

In response an upbeat second-quarter report and bullish guidance, shares of Illumina (NASDAQ: ILMN), a leading provider of genetic testing equipment, rose Wednesday morning. The stock was up by 13.3% as of 12:11 p.m. EDT.

Here's are the highlights from Illumina's second quarter:

Management credited the strong Q2 performance to huge demand for the company's new NovaSeq platform. Those results also allowed management to raise its guidance for rest of 2017:

Continue reading

Source: Fool.com